Talphera Inc. Company Profile
NASDAQ: TLPHHealthcareDrug Manufacturers - Specialty & GenericUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Talphera at a glance
Talphera Inc. (NASDAQ: TLPH) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector headquartered in San Mateo, CA. Talphera is led by Mr. Vincent J. Angotti and employs about 12 people. The company's shares have traded publicly since 2011.
At a market capitalization of $56.1 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001427925, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Talphera do?
Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate, Niyad, is a lyophilized formulation of nafamostat that acts as a regional anticoagulant for infusion into the extracorporeal circuit. It is also developing LTX-608, a lyophilized vial containing nafamostat for IV infusion for disseminated intravascular coagulation, acute respiratory distress syndrome, acute pancreatitis, and an anti-viral treatment; Fedsyra, an ephedrine pre-filled syringe for injection; and a phenylephrine pre-filled syringe for injection. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.
Business description based on the company's public filings.
Company information
- Legal name
- Talphera Inc.
- Ticker
- NASDAQ: TLPH
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Vincent J. Angotti
- Employees
- 12
- Headquarters
- 1850 Gateway Drive, San Mateo, CA, United States
- Phone
- 650 216 3500
- Website
- talphera.com
- IPO year
- 2011
- Market cap
- $56.06M
- SEC CIK
- 0001427925
Companies similar to Talphera
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ZYBTZhengye Biotechnology Holding Limited Class A | 1.15 | -0.87% | $54.50M | vs TLPH |
| SCYXSCYNEXIS Inc. | 4.22 | -11.72% | $41.99M | vs TLPH |
| CPHIChina Pharma Holdings Inc. | 0.96 | +12.94% | $41.30M | vs TLPH |
| IXHLIncannex Healthcare Inc. | 3.20 | +0.63% | $40.14M | vs TLPH |
| INCRIntercure Ltd. | 5.03 | -1.95% | $75.47M | vs TLPH |
| RMTIRockwell Medical Inc. | 8.02 | -2.43% | $32.32M | vs TLPH |
| SHPHShuttle Pharmaceuticals Holdings Inc. | 5.55 | +17.83% | $26.44M | vs TLPH |
| CTORCitius Oncology Inc. | 0.835 | -2.45% | $88.31M | vs TLPH |